Company & Sponsor Intelligence
Hadassah Medical Organization
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials6
Recruiting0
Completed5
Countries1
Therapeutic footprint
adhdautismmultiple_sclerosisptsd
Indexed studies
NCT01448252T Cell Vaccination in Patients With Progressive Multiple Sclerosis
multiple_sclerosis · IsraelPHASE1, PHASE2
multiple_sclerosis · IsraelPHASE1, PHASE2
NCT00843141The Efficacy of Computerized Cognitive Training in Adults With ADHD: Change in ADHD Symptoms, Executive Functions and Quality of Life Following Three Months of Training.
adhd · IsraelNA
adhd · IsraelNA
NCT02681575Meta-cognitive Functional Intervention for Adults With ADHD: A Pilot Efficacy Study
adhd · IsraelNA
adhd · IsraelNA
NCT01686685Correlation of CXCR4 Expression in Premature Infants With a Diagnosis of Autism at 24 Months
autism · IsraelCOMPLETED
autism · IsraelCOMPLETED
NCT00146900Prevention of Post Traumatic Stress Disorder by Early Treatment
ptsd · IsraelNA
ptsd · IsraelNA
NCT00318162Trial of Low-Dose Naltrexone for Children With Pervasive Developmental Disorder (PDD)
autism · IsraelPHASE1, PHASE2
autism · IsraelPHASE1, PHASE2
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →